Study for Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery

Overview

About this study

The purpose of this study is to evaluate the impact of patient input on opioid prescribing and overall opioid use following gynecologic surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Female patients >18 years old.
  • Ability to provide informed consent.
  • Planned minimally invasive hysterectomy with the Department of Surgery.
    • Concomitant minimally invasive surgeries performed by Gynecology will be allowed.

Exclusion Criteria:

  • Non-English speaking.
  • Combined surgical cases with other surgical departments.
  • Planned laparotomy.
  • Surgery planned to last >4 hours.
  • Postoperative hospitalization planned for >7 days.
  • Planned use of oral opioids other than oxycodone postoperatively.
  • Pre-existing chronic pain conditions including: chronic pelvic pain, migraines, temporomandibular joint dysfunction syndrome, fibromyalgia, and interstitial cystitis.
  • Preoperative diagnosis of pelvic pain.
  • Chronic preoperative opioid use.
  • History of or current diagnosis of narcotic or alcohol dependence:
    • Screening question asked at preoperative appointment:Have you or are you currently dependent on narcotic medications or alcohol?
  • Desire for more opioids than standard therapy.
  • Postoperative decision of surgeon to prescribed more than standard therapy.
  • Allergy or contraindication to taking opioids, ibuprofen, or acetaminophen.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Johnny Yi, M.D.

Open for enrollment

Contact information:

Alicia Rankin

(480) 301-6995

Rankin.Alicia@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20441564

Mayo Clinic Footer